News
15h
TipRanks on MSNBioNTech’s Promising Phase III Study in Recurrent Endometrial Cancer
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The Canadian Press on MSN12h
Health Canada approves updated Pfizer, Moderna COVID-19 vaccines for fall
TORONTO — Health Canada has authorized updated COVID-19 vaccines by Pfizer and BioNTech and by Moderna for use this ...
15h
Zacks.com on MSNBMY vs GSK: Which Biopharma Bigwig Has Better Prospects for Now?
Bristol Myers leans on new launches to offset legacy drug declines, while GSK's diverse portfolio and strong HIV lineup keep growth on track.
The payoff in lives and hospital time saved runs at about 100 to 1 per dollar invested, which is a great deal by any standard ...
TORONTO, Aug. 22, 2025 /CNW/ - With thousands of press releases published each week, it can be difficult to keep up with ...
The biotech company said Friday the latest version of its Covid-19 mRNA vaccine, Spikevax, has been authorized by Health Canada. And for the first time, all pre-filled syringe doses of the vaccine ...
The Emeryville, California-based biotech has just released topline results from a phase 1/2 head-to-head study comparing its ...
At the same time, the Food and Drug Administration has signaled that it will only approve updated Covid vaccines for ...
As a summer COVID-19 surge hits Michigan, unanswered questions abound about eligibility, insurance coverage and when new ...
19hOpinion
Calgary Herald on MSNBrookman: All we're asking for is the facts on vaccines and Air Canada
Second, now that we have learned Air Canada and the union have reached a tentative agreement, my question is why a 10-year ...
Dr. James Hildreth, president and CEO of Meharry Medical College and a veteran epidemiologist, said he was "baffled" by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results